Answers are grounded in this paper and cite their sources.
Treatment with phenobarbital of rats which are genetically selected results in a greater than 10-fold increase in nicotinamide-adenine dinucleotide (NAD)-dependent aldehyde dehydrogenase present in the supernatant but not the mitochondrial fraction of liver. This effect represents one of only a few known cases where intrastrain differences in a drug-induced increase in enzyme activity is genetically controlled. The kinetic characteristics of the enzyme from phenobarbital-treated rats are the same, regardless of whether or not the enzyme activity in the liver is increased. It is also demonstrated that rat liver supernatant contains a second NAD-dependent aldehyde dehydrogenase which (a) is resistant to induction by phenobarbital; (b) oxidizes p-carboxybenzaldehyde; (c) is relatively uninhibited by disulfiram; (d) has a heat stability different from the inducible enzyme.
No takes yet. Share an insight, caveat, or question.
Deitrich et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: